La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
STAAR Surgical Gestione
Gestione criteri di controllo 0/4
STAAR Surgical's Il CEO è Tom Frinzi, nominato in Jan2023, e ha un mandato di 1.58 anni. la retribuzione annua totale è $ 10.22M, composta da 7.7% di stipendio e 92.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.046% delle azioni della società, per un valore di $ 862.71K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.6 anni e 2.9 anni.
Informazioni chiave
Tom Frinzi
Amministratore delegato
US$10.2m
Compenso totale
| Percentuale dello stipendio del CEO | 7.7% |
| Mandato del CEO | 1.6yrs |
| Proprietà del CEO | 0.05% |
| Durata media del management | 1.6yrs |
| Durata media del Consiglio di amministrazione | 2.9yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 10
STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear
Aug 05The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing
Jul 12Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
May 27Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher
Apr 26STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge
Apr 05STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue
Mar 25STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade
Mar 13STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump
Mar 07Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
Jan 31With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For
Jan 05Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)
Nov 30Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?
Nov 12Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?
Oct 25Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes
Aug 24Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?
Jul 02Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?
Jun 17Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
May 13A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Mar 26STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital
Mar 12Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?
Feb 13Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
Jan 28Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Dec 15The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising
Dec 01What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?
Oct 26Keep Adding To STAAR Surgical Longs, Buy Thesis Remains
Sep 20Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?
Sep 05STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 21STAAR Surgical rises 15% on Q2 result beat
Aug 11Should You Think About Buying STAAR Surgical Company (NASDAQ:STAA) Now?
Jul 20STAAR Surgical: Hard Data Approach Justifies Long-Only Portfolio Allocation
Jul 05Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 28 2024 | n/a | n/a | US$17m |
| Mar 29 2024 | n/a | n/a | US$15m |
| Dec 29 2023 | US$10m | US$788k | US$21m |
| Sep 29 2023 | n/a | n/a | US$19m |
| Jun 30 2023 | n/a | n/a | US$26m |
| Mar 31 2023 | n/a | n/a | US$33m |
| Dec 30 2022 | US$274k | n/a | US$40m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jul 01 2022 | n/a | n/a | US$34m |
| Apr 01 2022 | n/a | n/a | US$29m |
| Dec 31 2021 | US$250k | n/a | US$28m |
| Oct 01 2021 | n/a | n/a | US$23m |
| Jul 02 2021 | n/a | n/a | US$21m |
| Apr 02 2021 | n/a | n/a | US$11m |
| Jan 01 2021 | US$182k | n/a | US$6m |
Compensazione vs Mercato: La retribuzione totale di Tom ($USD 10.22M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 5.62M ).
Compensazione vs guadagni: La retribuzione di Tom è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Tom Frinzi (68 yo)
1.6yrs
Mandato
US$10,220,581
Compensazione
Mr. Thomas G. Frinzi, also known as Tom, serves as Executive Chairman of the Board at ViaLase, Inc. since November 2022 and joined the company in November 2022. He serves as Executive Chair at Aurion Biote...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 1.6yrs | US$10.22m | 0.046% $ 862.7k | |
| Chief Financial Officer | 4.1yrs | US$2.82m | 0.070% $ 1.3m | |
| Chief Operating Officer | 1.3yrs | US$3.42m | 0.0089% $ 165.2k | |
| Chief Technology Officer | 7.4yrs | US$2.41m | 0.036% $ 673.9k | |
| Chief Medical Officer | 6.8yrs | US$2.48m | 0.064% $ 1.2m | |
| Vice President of Investor Relations & Corporate Development | no data | Nessun dato | Nessun dato | |
| General Counsel & Corporate Secretary | less than a year | Nessun dato | Nessun dato | |
| Chief Marketing Officer | less than a year | Nessun dato | Nessun dato | |
| Senior Vice President of Commercial Operations - North America & APAC | 7.8yrs | US$2.54m | 0.060% $ 1.1m | |
| Chief Clinical | 1.3yrs | Nessun dato | 0.0061% $ 114.3k | |
| Senior Vice President of Operations | no data | Nessun dato | 0.066% $ 1.2m |
1.6yrs
Durata media
60.5yo
Età media
Gestione esperta: Il team dirigenziale di STAA non è considerato esperto (durata media 1.6 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 4.2yrs | US$10.22m | 0.046% $ 862.7k | |
| Lead Independent Director | 8.6yrs | US$294.87k | 0.031% $ 574.5k | |
| Independent Director | 2.2yrs | US$259.96k | 0.031% $ 582.0k | |
| Independent Director | less than a year | US$99.69k | 0.0093% $ 173.4k | |
| Member of Optometric Advisory Council | 15.8yrs | Nessun dato | Nessun dato | |
| Independent Director | less than a year | Nessun dato | 0.0059% $ 109.6k | |
| Independent Director | less than a year | Nessun dato | 0.0072% $ 134.4k | |
| Independent Director | 3.6yrs | US$249.99k | 0.010% $ 193.3k |
2.9yrs
Durata media
55yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di STAA non è considerato esperto (durata media del mandato 2.9 anni), il che suggerisce un nuovo consiglio.